ClinicaliQ Trial Snapshot
- Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina — Recruiting • Cardiology / Cardiovascular • NCT07864025.
- What is being tested: A novel combination of multimodality intravascular imaging and advanced photon-counting CT technology to characterize and identify high-risk coronary plaque lesions in patients with stable angina, potentially improving risk stratification beyond current imaging methods.
- Patient eligibility overview: Adults with stable angina undergoing coronary angiography who are suitable for intravascular imaging procedures; likely excluding those with acute coronary syndromes, severe renal impairment, or contraindications to invasive coronary imaging.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Coronary artery disease, caused by the furring up of the heart arteries by atherosclerosis, is a major cause of death in the UK. Despite existing therapies, adverse cardiovascular events remains high, especially in patients who have already had a heart attack, as some of these patients have aggressive atherosclerotic disease. If we could identify these vulnerable patients, then in wider clinical practice in the future we might be able to treat them better with new therapies that can otherwise be expensive or come with a risk of side-effects. Traditionally, the…
Eligibility Snapshot
- : * Able and willing to give informed consent * Between ages 18-79 * Patients with a stable coronary syndrome that had recent PC-CTA showing at least one lesion requiring further evaluation with intravascular imaging or fractional flow reserve and is considered suitable for PCI under IVUS guidance
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.